Header Logo

Connection

JAMES WELSH to Recurrence

Back to Details
This is a "connection" page, showing publications JAMES WELSH has written about Recurrence.
JAMES WELSH
Connection Strength
0.030
Recurrence
  1. Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial. Lancet. 2023 09 09; 402(10405):871-881.
    View in: PubMed
    Score: 0.030
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.